Skip to main content

Top 3 cannabis risks as stocks soar

| thcscout | | No Comments on Top 3 cannabis risks as stocks soar

Share

  • No bookmark found
#brainhealth #addictionrecovery #doctor

Cannabis is reclassified, but what does it mean for your brain? Learn what’s revealed about your brain on cannabis when you’re unconscious.

💛 Visit Dr. Kaveh’s longevity clinic for ketamine therapy, bioidentical hormone replacement therapy, and more: https://www.clarus-health.com
🫀 Exclusive access to Dr. Kaveh’s live streams + more: https://www.youtube.com/channel/UCl31nh9FGrKKGjKn8uaOasw/join

This video/speech/channel DOES NOT CONSTITUTE MEDICAL ADVICE. Patients with medical concerns should contact their physician. If your concern is an emergency, immediately call 911. This information is not a recommendation for ANY THERAPY. Some substances referenced in this content may be illegal, and this content is not a recommendation for, or endorsement of, their use in any way.

References:
Gorelick DA. Cannabis-related disorders and toxic effects. N Engl J Med. 2023;389(24):2267–2275. doi:10.1056/NEJMra2212152

Page RL, Allen LA, Kloner RA, et al. Medical marijuana, recreational cannabis, and cardiovascular health: a scientific statement from the American Heart Association. Circulation. 2020;142(10):e131–e152. doi:10.1161/CIR.0000000000000883

Volkow ND, Baler RD, Compton WM, Weiss SR. Adverse health effects of marijuana use. N Engl J Med. 2014;370(23):2219–2227. doi:10.1056/NEJMra1402309

American Psychiatric Association. Resource Document on Opposition to Cannabis as Medicine. Washington, DC: American Psychiatric Association; 2018.

Leung J, Chan GCK, Hides L, Hall WD. What is the prevalence and risk of cannabis use disorders among people who use cannabis? A systematic review and meta-analysis. Addict Behav. 2020;109:106479. doi:10.1016/j.addbeh.2020.106479

Hsu M, Shah A, Jordan A, Gold MS, Hill KP. Therapeutic use of cannabis and cannabinoids. JAMA. 2025. doi:10.1001/jama.2025.19433

Hall W, Stjepanović D, Caulkins J, et al. Public health implications of legalising the production and sale of cannabis for medicinal and recreational use. Lancet. 2019;394(10208):1580–1590. doi:10.1016/S0140-6736(19)31789-1

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed, text revision (DSM-5-TR). Washington, DC: American Psychiatric Association; 2022.

Connor JP, Stjepanović D, Le Foll B, et al. Cannabis use and cannabis use disorder. Nat Rev Dis Primers. 2021;7(1):16. doi:10.1038/s41572-021-00247-4